State Street
CRBU icon

State Street’s Caribou Biosciences CRBU Stock Holding History

State Street’s Portfolio CRBU Stock Details CRBU Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$804K Hold
423,263
– – ﹤0.01% 3539
2025
Q4 		$673K Buy
423,263
+37,000
+10% +$77.7K ﹤0.01% 3608
2025
Q3 		$900K Buy
386,263
+28,100
+8% +$53K ﹤0.01% 3535
2025
Q2 		$451K Sell
358,163
-1,283,018
-78% -$1.26M ﹤0.01% 3635
2025
Q1 		$1.5M Sell
1,641,181
-16,380
-1% -$21.3K ﹤0.01% 3337
2024
Q4 		$2.64M Buy
1,657,561
+39,318
+2% +$79.1K ﹤0.01% 3228
2024
Q3 		$3.17M Buy
1,618,243
+2,664
+0.2% +$5.46K ﹤0.01% 3158
2024
Q2 		$2.65M Sell
1,615,579
-4,731,742
-75% -$15.1M ﹤0.01% 3205
2024
Q1 		$32.6M Buy
6,347,321
+1,227,655
+24% +$7.57M ﹤0.01% 1945
2023
Q4 		$29.3M Sell
5,119,666
-233,723
-4% -$1.16M ﹤0.01% 1993
2023
Q3 		$25.6M Buy
5,353,389
+4,283,243
+400% +$26.6M ﹤0.01% 2021
2023
Q2 		$4.55M Sell
1,070,146
-2,285,146
-68% -$10.3M ﹤0.01% 3037
2023
Q1 		$17.8M Buy
3,355,292
+156,399
+5% +$974K ﹤0.01% 2313
2022
Q4 		$20.1M Buy
3,198,893
+803,423
+34% +$7.15M ﹤0.01% 2244
2022
Q3 		$25.3M Buy
2,395,470
+1,597,870
+200% +$14.9M ﹤0.01% 2050
2022
Q2 		$4.33M Buy
797,600
+54,578
+7% +$417K ﹤0.01% 3165
2022
Q1 		$6.82M Buy
743,022
+330,074
+80% +$3.48M ﹤0.01% 3029
2021
Q4 		$6.23M Buy
412,948
+129,359
+46% +$2.52M ﹤0.01% 3135
2021
Q3 		$6.77M Buy
+283,589
New +$6.93M ﹤0.01% 3078

Other funds holding CRBU

P
Pfizer New York $239M AUM 232.47% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
KCM
Kynam Capital Management Princeton, New Jersey $1.62B AUM 138.67% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Aberdeen Group
Aberdeen Group Edinburgh, United Kingdom $61.9B AUM 29.81% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

State Street's CRBU Position: Q1 2026 in Review

State Street held its Caribou Biosciences (CRBU) position steady in Q1 2026 at 423,263 shares worth $804K. The position accounts for ﹤0.01% of the portfolio, ranked #3539.

State Street first reported a position in CRBU in Q3 2021 and has held it in 19 quarters since. The position peaked at $32.6M in Q1 2024. 137 funds tracked by Wall St. Rank hold CRBU as of Q1 2026.

  • State Street held 423,263 shares of Caribou Biosciences worth $804K as of Q1 2026.
  • State Street left its Caribou Biosciences share count unchanged in Q1 2026.
  • Caribou Biosciences made up ﹤0.01% of State Street's portfolio in Q1 2026, its #3539 holding.
  • State Street first reported a position in Caribou Biosciences in Q3 2021 and has held it in 19 quarters since.
  • State Street's Caribou Biosciences position peaked at $32.6M in Q1 2024.
  • 137 funds tracked by Wall St. Rank held Caribou Biosciences as of Q1 2026.

Based on State Street's 13F filing for Q1 2026, filed 15 May 2026.